MH-080
N/A
Report date: 2023/04/11 20:00:23
NME
Base Information
Drug NameMH-080
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesMinghui Pharmaceutical (Hangzhou) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAmerican New Jersey Ostar Pharmaceutical Co LtdMinghui Pharmaceutical (Hangzhou) Co LtdMing Ren Pharmaceutical Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A